Back to Defining Moments
Inspirational people, scientific discoveries, and transformative partnerships that have shaped who we are.
“We gotta still have fun. We gotta still dress up in crazy outfits and do silly things.” -Bob Swanson, Genentech Co-founder
Results presented at ASCO 2005 fundamentally changed the treatment of early HER2-positive breast cancer.
In 2013, the FDA approved the first medicine under its new, faster Breakthrough Therapy Designation pathway.
Tell us what you think about our company, products, or website.
The way to do research is to attack the facts at the point of greatest astonishment.